Similar articles

• [Effects on arterial pressure of administration of a single dose (5 mg/per os) of bromocryptine].

  Steardo L, Sorge F, Florio C, Marano E, Bonuso S, de Martino G. Steardo L, et al. Acta Neurol Quad (Napoli). 1978;37:98-104. Acta Neurol Quad (Napoli). 1978. PMID: 757112 Italian. No abstract available.
• Pizotifen in the management of migraine.

  Bademosi O, Osuntokun BO. Bademosi O, et al. Practitioner. 1978 Feb;220(1316):325-7. Practitioner. 1978. PMID: 345259 Clinical Trial. No abstract available.
• Propranolol in the treatment of migraine.

  Behan PO, Reid M. Behan PO, et al. Practitioner. 1980 Feb;224(1340):201-3. Practitioner. 1980. PMID: 6988825 Clinical Trial. No abstract available.
• [Methodology of clinical trials in migraine: a rating system].

  Tzourio C, Massiou H, Bousser MG. Tzourio C, et al. Pathol Biol (Paris). 1992 Apr;40(4):361-6. Pathol Biol (Paris). 1992. PMID: 1495821 Review. French.
• Botulinum toxin type A (BOTOX) for treatment of migraine.

  Binder WJ, Brin MF, Blitzer A, Pogoda JM. Binder WJ, et al. Semin Cutan Med Surg. 2001 Jun;20(2):93-100. doi: 10.1053/sder.2001.24423. Semin Cutan Med Surg. 2001. PMID: 11474749 Review.